Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gray

Showing results (181-190 of 195) with videos related to

Pageof 20
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Spatiotemporal controlled delivery of nanoparticles to injured vasculatureJuliana M Chan, Liangfang Zhang, Rong Tong, et al.
Journal of Neuroinflammation|January 31, 2025
Rescue of in vitro models of CSF1R-related adult-onset leukodystrophy by iluzanebart: mechanisms and therapeutic implications of TREM2 agonismKelley C Larson, Frederick W Gergits, Abigail J Renoux, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2021
Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman PrimatesOlivier Barret, Lei Zhang, David Alagille, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 13, 2014
MyD88 signaling inhibits protective immunity to the gastrointestinal helminth parasite Heligmosomoides polygyrusLisa A Reynolds, Yvonne Harcus, Katherine A Smith, et al.
Journal of Medicinal Chemistry|November 16, 2018
Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced DesensitizationJennifer E Davoren, Deane Nason, Jotham Coe, et al.
Bioorganic & Medicinal Chemistry Letters|July 14, 2024
Discovery of the first selective, small-molecule GFRα2/3 inhibitors through DNA-encoded library technologyShea L Johnson, Galen Missig, Minghua Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2021
Risk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID-19: A Binational, Registry-Based Cohort StudyMatthew A Rutherford, Jennifer Scott, Maira Karabayas, et al.
ACS Chemical Biology|November 10, 2012
Allosteric competitive inhibitors of the glucose-1-phosphate thymidylyltransferase (RmlA) from Pseudomonas aeruginosaMagnus S Alphey, Lisa Pirrie, Leah S Torrie, et al.
Plos One|July 16, 2021
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodiesLee A Armstrong, Sven M Lange, Virginia Dee Cesare, et al.
Plos One|April 16, 2024
Correction: Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodiesLee A Armstrong, Sven M Lange, Virginia De Cesare, et al.
Pageof 20

Showing results (181-190 of 195) with videos related to

Sort By:
Pageof 20
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Spatiotemporal controlled delivery of nanoparticles to injured vasculatureJuliana M Chan, Liangfang Zhang, Rong Tong, et al.
Journal of Neuroinflammation|January 31, 2025
Rescue of in vitro models of CSF1R-related adult-onset leukodystrophy by iluzanebart: mechanisms and therapeutic implications of TREM2 agonismKelley C Larson, Frederick W Gergits, Abigail J Renoux, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2021
Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman PrimatesOlivier Barret, Lei Zhang, David Alagille, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 13, 2014
MyD88 signaling inhibits protective immunity to the gastrointestinal helminth parasite Heligmosomoides polygyrusLisa A Reynolds, Yvonne Harcus, Katherine A Smith, et al.
Journal of Medicinal Chemistry|November 16, 2018
Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced DesensitizationJennifer E Davoren, Deane Nason, Jotham Coe, et al.
Bioorganic & Medicinal Chemistry Letters|July 14, 2024
Discovery of the first selective, small-molecule GFRα2/3 inhibitors through DNA-encoded library technologyShea L Johnson, Galen Missig, Minghua Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2021
Risk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID-19: A Binational, Registry-Based Cohort StudyMatthew A Rutherford, Jennifer Scott, Maira Karabayas, et al.
ACS Chemical Biology|November 10, 2012
Allosteric competitive inhibitors of the glucose-1-phosphate thymidylyltransferase (RmlA) from Pseudomonas aeruginosaMagnus S Alphey, Lisa Pirrie, Leah S Torrie, et al.
Plos One|July 16, 2021
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodiesLee A Armstrong, Sven M Lange, Virginia Dee Cesare, et al.
Plos One|April 16, 2024
Correction: Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodiesLee A Armstrong, Sven M Lange, Virginia De Cesare, et al.
Pageof 20